30
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Correlation between unproven therapies and delayed return-to-work for COVID-19-infected healthcare workers

, , , , , , , , & ORCID Icon show all
Pages 45-56 | Received 07 Dec 2023, Accepted 04 May 2024, Published online: 20 May 2024

References

  • Zhu J, Ji P, Pang J, et al. Clinical characteristics of 3062 COVID‐19 patients: a meta‐analysis. J Med Virol. 2020;92(10):1902–1914. doi:10.1002/jmv.25884.
  • Borges do Nascimento IJ, von Groote TC, O’Mathúna DP, et al. Clinical, laboratory and radiological characteristics and outcomes of novel coronavirus (SARS-CoV-2) infection in humans: a systematic review and series of meta-analyses. PLoS One. 2020;15(9):e0239235. doi:10.1371/journal.pone.0239235.
  • Tong JY, Wong A, Zhu D, Fastenberg JH, Tham T. The prevalence of olfactory and gustatory dysfunction in COVID‐19 patients: a systematic review and meta‐analysis. Otolaryngol Head Neck Surg. 2020;163(1):3–11. doi:10.1177/0194599820926473.
  • Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull. 2020 Jan;25(3):2000045. doi:10.2807/1560-7917.ES.2020.25.3.2000045.
  • Bernard Stoecklin S, Rolland P, Silue Y, et al. First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020. Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull. 2020;25(6):2000094.
  • Saglietto A, D'Ascenzo F, Zoccai GB, De Ferrari GM. COVID-19 in Europe: the Italian lesson. Lancet. 2020;395(10230):1110–1111. doi:10.1016/S0140-6736(20)30690-5.
  • Souris M, Gonzalez JP. COVID-19: Spatial analysis of hospital case-fatality rate in France. PLoS One. 2020;15(12):e0243606. doi:10.1371/journal.pone.0243606.
  • Chowell G, Abdirizak F, Lee S, et al. Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study. BMC Med. 2015;13(1):210. doi:10.1186/s12916-015-0450-0.
  • Buonafine CP, Paiatto BNM, Leal FB, et al. High prevalence of SARS-CoV-2 infection among symptomatic healthcare workers in a large university tertiary hospital in São Paulo, Brazil. BMC Infect Dis. 2020;20(1):917. doi:10.1186/s12879-020-05662-8.
  • Gómez-Ochoa SA, Franco OH, Rojas LZ, et al. COVID-19 in health-care workers: a living systematic review and meta-analysis of prevalence, risk factors, clinical characteristics, and outcomes. Am J Epidemiol. 2021;190(1):161–175. doi:10.1093/aje/kwaa191.
  • Noel L, Marion E, Boufercha R, et al. Screening of health workers exposed to SARS-CoV-2 in a university hospital in the south of France. Int Arch Occup Environ Health. 2022;95(2):419–424. doi:10.1007/s00420-021-01789-6.
  • Garzillo EM, Cioffi A, Carta A, Monaco MGL. Returning to work after the COVID-19 pandemic earthquake: a systematic review. Int J Environ Res Public Health. 2022;19(8):4538. doi:10.3390/ijerph19084538.
  • National Center for Immunization and Respiratory Diseases (U.S.). CDC. Criteria for return to work for healthcare personnel with confirmed or suspected COVID-19 (interim guidance). 2020.
  • French High Council for Public Health (Haut Conseil de la santé publique, HCSP). SARS coronavirus-2: clinical criteria for safely ending isolation of infected patients. French High Council for Public Health (Haut Conseil de la santé publique, HCSP); 2020.
  • Shenoy ES, West LR, Hooper DC, et al. Healthcare worker infection with SARS-CoV-2 and test-based return to work. Infect Control Hosp Epidemiol. 2020;41(12):1464–1466. doi:10.1017/ice.2020.438.
  • Villarreal J, Nieto SV, Vázquez F, Del Campo MT, Mahillo I, De La Hoz RE. Time to a negative SARS-CoV-2 PCR predicts delayed return to work after medical leave in COVID-19 infected health care workers. J Occup Environ Med. 2021;63(11):970–974. doi:10.1097/JOM.0000000000002336.
  • Chaudhry ZS, Cadet L, Sharip A. Return to work, demographic predictors, and symptomatic analysis among healthcare workers presenting for COVID-19 testing: a retrospective cohort from a united states academic occupational medicine clinic from. Cureus. 2021;13(11):e19944. https://www.cureus.com/articles/77450-return-to-work-demographic-predictors-and-symptomatic-analysis-among-healthcare-workers-presenting-for-covid-19-testing-a-retrospective-cohort-from-a-united-states-academic-occupational-medicine-clinic
  • Kolodziej LM, Hordijk S, Koopsen J, et al. Risk of SARS-CoV-2 transmission upon return to work in RNA-positive healthcare workers. J Hosp Infect. 2022;24:72–78. doi:10.1016/j.jhin.2022.02.024.
  • Ganz-Lord FA, Segal KR, Rinke ML. COVID-19 symptoms, duration, and prevalence among healthcare workers in the New York metropolitan area. Infect Control Hosp Epidemiol. 2021;42(8):917–923. doi:10.1017/ice.2020.1334.
  • Markov PV, Ghafari M, Beer M, et al. The evolution of SARS-CoV-2. Nat Rev Microbiol. 2023;21(6):361–379. doi:10.1038/s41579-023-00878-2.
  • Jacobsen PA, Andersen MP, Gislason G, et al. Return to work after COVID-19 infection – A Danish nationwide registry study. Public Health. 2022;203:116–122. doi:10.1016/j.puhe.2021.12.012.
  • Kisiel MA, Nordqvist T, Westman G, Svartengren M, Malinovschi A, Janols H. Patterns and predictors of sick leave among Swedish non-hospitalized healthcare and residential care workers with Covid-19 during the early phase of the pandemic. Huang HK, editor. PLoS One. 2021;16(12):e0260652. doi:10.1371/journal.pone.0260652.
  • French High Council for Public Health (Haut Conseil de la santé publique, HCSP). Provisional statement: patients at risk of severe forms of Covid-19 and prioritising access to diagnostic tests. French High Council for Public Health (Haut Conseil de la santé publique, HCSP); 2020.
  • Ministère français de la Transformation et de la Fonction publiques. Rapport annuel sur l’état de la fonction publique - Edition 2021. Direction générale de l’administration et de la fonction publique; 2021.
  • OECD. Paid sick leave to protect income, health and jobs throughthe COVID-19 crisis [Internet]. 2020. https://read.oecd-ilibrary.org/view/?ref=134_134797-9iq8w1fnju&title=Paid-sick-leave-to-protect-income-health-and-jobs-through-the-COVID-19-crisis.
  • Yan D, Zhang X, Chen C, et al. Characteristics of viral shedding time in SARS-CoV-2 infections: a systematic review and meta-analysis. Front Public Health. 2021;9:652842. doi:10.3389/fpubh.2021.652842.
  • Cevik M, Tate M, Lloyd O, Maraolo AE, Schafers J, Ho A. SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis. Lancet Microbe. 2021;2(1):e13–22–e22. doi:10.1016/S2666-5247(20)30172-5.
  • Domeracki S, Clapp RN, Taylor K, Lu CM, Lampiris H, Blanc PD. Cycle Threshold to Test Positivity in COVID-19 for Return to Work Clearance in Health Care Workers. J Occup Environ Med. 2020;62(11):889–891. doi:10.1097/JOM.0000000000001996.
  • Puhach O, Meyer B, Eckerle I. SARS-CoV-2 viral load and shedding kinetics. Nat Rev Microbiol. 2022;21(3):147–161. https://www.nature.com/articles/s41579-022-00822-w
  • Rahmani A, Dini G, Leso V, et al. Duration of SARS-CoV-2 shedding and infectivity in the working age population: a systematic review and meta-analysis. Med Lav Work Environ Health. 2022;113(2):e2022014.
  • Martinelli D, Fortunato F, Mazzilli S, Bisceglia L, Lopalco PL, Prato R. Estimating the Proportion of Asymptomatic COVID-19 Cases in an Italian Region with Intermediate Incidence during the First Pandemic Wave: An Observational Retrospective Study. Maida M, editor. Biomed Res Int. 2022;2022:3401566–3401566. doi:10.1155/2022/3401566.
  • Gholami M, Fawad I, Shadan S, et al. COVID-19 and healthcare workers: A systematic review and meta-analysis. Int J Infect Dis. 2021;104:335–346. doi:10.1016/j.ijid.2021.01.013.
  • Mutiawati E, Fahriani M, Mamada SS, et al. Anosmia and dysgeusia in SARS-CoV-2 infection: incidence and effects on COVID-19 severity and mortality, and the possible pathobiology mechanisms - a systematic review and meta-analysis. F1000Res. 2021;10:40. doi:10.12688/f1000research.28393.1.
  • Healey Q, Sheikh A, Daines L, Vasileiou E. Symptoms and signs of long COVID: A rapid review and meta-analysis. J Glob Health. 2022;12:05014. doi:10.7189/jogh.12.05014.
  • Zheng Y, Li T, Zhang Y, Luo H, Bai M, Liu Z, et al. COVID-19 Knowledge/Practices, Mental Status, and Return-To-Work Concerns Among Healthcare Workers in Huangzhou District, Huanggang City, China. Front Public Health. 2022 Jan 14;9:723118. doi:10.3389/fpubh.2021.723118.
  • Wang S, Zhang Y, Guan Y, et al. A nationwide evaluation of the prevalence of and risk factors associated with anxiety, depression and insomnia symptoms during the return-to-work period of coronavirus disease 2019 in China. Soc Psychiatry Psychiatr Epidemiol. 2021;56(12):2275–2286. doi:10.1007/s00127-021-02046-4.
  • Aymerich C, Pedruzo B, Pérez JL, et al. COVID-19 pandemic effects on health worker’s mental health: Systematic review and meta-analysis. Eur Psychiatry. 2022;65(1):e10. doi:10.1192/j.eurpsy.2022.1.
  • Dragioti E, Li H, Tsitsas G, et al. A large‐scale meta‐analytic atlas of mental health problems prevalence during the COVID‐19 early pandemic. J Med Virol. 2022;94(5):1935–1949. doi:10.1002/jmv.27549.
  • Nashwan AJ, Mathew RG, Anil R, et al. The safety, health, and well-being of healthcare workers during COVID-19: A scoping review. AIMS Public Health. 2023;10(3):593–609. doi:10.3934/publichealth.2023042.
  • Westerlind E, Palstam A, Sunnerhagen KS, Persson HC. Patterns and predictors of sick leave after Covid-19 and long Covid in a national Swedish cohort. BMC Public Health. 2021;21(1):1023. doi:10.1186/s12889-021-11013-2.
  • Cavalcanti AB, Zampieri FG, Rosa RG, et al. Hydroxychloroquine with or without azithromycin in mild-to-moderate Covid-19. N Engl J Med. 2020;383(21):2041–2052. doi:10.1056/NEJMoa2019014.
  • Chivese T, Musa OAH, Hindy G, et al. Efficacy of chloroquine and hydroxychloroquine in treating COVID-19 infection: a meta-review of systematic reviews and an updated meta-analysis. Travel Med Infect Dis. 2021;43:102135. doi:10.1016/j.tmaid.2021.102135.
  • Lagier J-C, Million M, Gautret P, et al. Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: a retrospective analysis. Travel Med Infect Dis. 2020;36:101791. doi:10.1016/j.tmaid.2020.101791.
  • Martins-Filho PR, Ferreira LC, Heimfarth L, Araújo AADS, Quintans-Júnior LJ. Efficacy and safety of hydroxychloroquine as pre-and post-exposure prophylaxis and treatment of COVID-19: A systematic review and meta-analysis of blinded, placebo-controlled, randomized clinical trials. Lancet Reg Health Am. 2021;2:100062. doi:10.1016/j.lana.2021.100062.
  • Ghazy RM, Almaghraby A, Shaaban R, et al. A systematic review and meta-analysis on chloroquine and hydroxychloroquine as monotherapy or combined with azithromycin in COVID-19 treatment. Sci Rep. 2020;10(1):22139. doi:10.1038/s41598-020-77748-x.
  • Lynch HF, Lundin D, Meagher EA. Ethical inclusion of health care workers in Covid‐19 research. Ethics Hum Res. 2021;43(2):19–27. doi:10.1002/eahr.500082.
  • Ramesh M, Syed J, Sri Harsha C. Ethical considerations and clinical trials during a pandemic: a blessing with a burden. Clin Ethics. 2022;17(4):331–333. doi:10.1177/14777509211034138.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.